Key | % Net Assets |
---|---|
![]() |
2.4% |
![]() |
2.2% |
![]() |
2.2% |
![]() |
2.1% |
![]() |
91.1% |
Name | % Net Assets |
---|---|
Reed Elsevier N.V. | 2.4% |
Sanofi-Aventis S.A. | 2.2% |
Allianz SE | 2.2% |
Enagas S.A. | 2.1% |
Heineken N.V. | 2.0% |
Novartis AG | 2.0% |
Red Electrica Corp. S.A. | 1.9% |
Societe Generale S.A. (France) | 1.7% |
Vivendi S.A. | 1.6% |
Julius Baer Group AG | 1.4% |
Key | % Net Assets |
---|---|
![]() | 21.60% |
![]() | 17.10% |
![]() | 14.60% |
![]() | 12.90% |
![]() | 12.20% |
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | 28/05/2004 |
---|---|
Fund Manager | n/a |
TER | 1.24 (30-Apr-2011) |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research